This newest report presents information on the size of the prescription drug industry as measured within the context of the entire Polish pharmacy market, reviews its performance in 2002-2005 and formulates forecasts for 2006-2008. The market size information is qualified by value (annual sales value) and volume (number of packages sold) as well as by the individual market segments:
domestic and foreign pharmaceuticals
refundable and non-refundable medicines
innovative and generic preparations
ATC categories
in-patient and out-patient pharmacy distribution.
Furthermore, the report delivers an insightful analysis of Rx drug pricing in the aforementioned segments and of the most recent changes on drug reimbursement lists.
The report is divided into the following sections:
Size of Polish Rx market
Detailed market analysis and forecasts
Drug prices in Poland
Foreign trade
Key factors material to Polish Rx market
Legal environment
Polish pharmaceutical industry
Drug distribution in Poland
This is a must have report for anyone from:
the top management of Rx drug makers active on the Polish market
the strategic planners and executives of companies considering market entry
drug distributors; including wholesalers, pharmacists and pharmacy chain owners
pharma industry associations
embassies, governmental agencies and chambers of commerce
financial institutions; including banks, brokerage houses and investment funds
firms specialising in legal advisory, consultancy and market research.

Report metodology 11
Executive summary 13
Overview of the Rx market in Poland 19
Major trends and events on the Rx
market in Poland 19
Major trends in 2005/2006 19
Key events in 2005/2006 20
Size of the Polish Rx market against the backdrop
of pharmacy market in 2002-2005 21
Value of Rx market 21
Rx sales volume 22
Domestic and foreign Rx drugs 23
Rx innovative and generic drugs 26
Size of hospital market 27
Value of the hospital market and key growth drivers 27
Largest therapeutic groups in the hospital market 29


Forecasts for pharmacy market 30
Foreign and domestic drugs 32
Generic and innovative drugs 35
Forecasts for hospital market 36
Rx drug pricing in Poland 37
Average prices of Rx drugs 37
Average prices of reimbursed drugs 38
Reimbursement and pharmacy sales 39
Average prices by therapeutic categories 40
Changes to drug prices proposed in the
amendment to the Pharmaceutical Law 41
Rx market by therapeutic categories 43
Largest therapeutic categories of Rx
drugs on pharmacy market 43
Cardiovascular system 46
Market size and forecasts 46
Key ATC subcategories of drugs used
in cardiovascular diseases 46
Central nervous system 49
Market size and forecasts 49
Key ATC subcategories of drugs used
in central nervous system diseases 50
Alimentary tract and metabolism 52
Market size and forecasts 52
Key ATC subcategories of drugs used
in alimentary tract and metabolic diseases 53

Respiratory system 57
Market size and forecasts 57
Key ATC subcategories of drugs used
in respiratory system diseases 58
Anti-infectives 60
Market size and forecasts 60
Key ATC subcategories of general
anti-infectives systemic 61
Musculo-skeletal system 62
Market size and forecasts 62
Key ATC subcategories of drugs used
in musculo-skeletal system diseases 63
Genito-urinary system 64
Market size and forecasts 64
Key ATC subcategories of drugs used
in genito-urinary system diseases 64
Antineoplastics and immunomodulating agents 65
Market size and forecasts 65
Key ATC subcategories of antineoplastics
and immunomodulating agents 66
Blood and blood forming organs 67
Market size and forecasts 67
Key ATC subcategories of drugs in the “Blood and blood
forming organs” group 67
Other ATC groups 68
Dermatologicals 68
Sensory organs 68
Systemic hormonal preparations
(excluding sex hormones) 69
Parasiticides, insecticides and repellents 69


Pharmaceutical companies in Poland 71
Number and classification of pharmaceutical
manufacturers in Poland 71
Manufacturers of pharmaceutical substances 71
Drug manufacturers 72
Economic analysis of Polish pharmaceutical sector 73
Output of selected pharmaceutical products 73
Revenues 74
Profit 75
Operating expenses 76
Employment 76
Foreign trade 78
Ranking of the largest drug
manufacturers (groups) 82
Key players on Rx market 82
Key players in pharmacy drug market 86
Profiles of major Rx market players 91
Ranking of the largest Rx manufacturers
(individual manufacturers) 99
Investment projects in the Polish
pharmaceutical sector in 2005 101
Number of investment projects in 2005 101
Value of investments in 2005 101
Capital expenditure on intangible assets 102
Major foreign investment projects in pharmaceutical
sector in 2005 and 2006 103


Factors influencing the Rx market 109
Demographic trends 109
Population 109
Aging of society 110
Life expectancy 111
Epidemiological trends 112
Prevalence of chronic diseases 112
Epidemiology of selected diseases in Polish society 114
Subjective assessment of health 124
Consumer attitudes 125
Drug intake in Poland 125
Drug expenditure in Poland 126
Poles’ information needs 127
Drug availability 130
Purchase of prescribed drugs 130
Confidence in healthcare institutions 132
Familiarity of pharmaceutical companies 132
Attitudes towards foreign and domestic
manufacturers 133
Legal environment 134
Main legislation and institutions ruling Rx
pharmaceuticals in Poland 134
Key changes in amended Pharmaceutical Law 135
Key changes in the Healthcare Act 142
Legal changes in drug distribution 143

Drug distribution in Poland 147
Pharmaceutical wholesalers 147
Leading players 147
Types of wholesalers 150
Key events and trends on wholesale
market in 2005 and 2006 152
Anticipated trends on wholesale market 153
Pharmacy distribution 154
Pharmacies 154
Pharmacy chains 157
Pharmacy points 159
Online pharmacies 161
List of graphs 163
List of tables 169
About PMR 173
Contact PMR 174